The link between insulin resistance and preeclampsia: new perspectives

Journal of Reproductive Immunology

Volumn 82, Issue 2, 2009, Pages 100-105

  Scioscia, Marco ^a,b   Gumaa, Khalid ^c   Rademacher, Thomas W ^d  

^a Sacro Cuore Don Calabria ^*  (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Gestational diabetes mellitus; Inositol phosphoglycan; Insulin resistance; Preeclampsia

Indexed keywords

ENDOGLIN; INOSITOL PHOSPHOGLYCAN P TYPE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHOLIPID; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; INOSITOL PHOSPHATE; INOSITOL PHOSPHATE GLYCAN; POLYSACCHARIDE;

DISEASE ASSOCIATION; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; MACROSOMIA; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; URINARY EXCRETION; ANIMAL; FEMALE; IMMUNOLOGY; PREGNANCY; RISK FACTOR;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; INOSITOL PHOSPHATES; INSULIN RESISTANCE; METABOLIC SYNDROME X; POLYSACCHARIDES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; RISK FACTORS;

EID: 77953442600     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.04.009     Document Type: Review

References (48)

1. Bartha J.L., Gonzalez-Bugatto F., Fernandez-Macias R., Gonzalez-Gonzalez N.L., Comino-Delgado R., and Hervias-Vivancos B. Metabolic syndrome in normal and complicated pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 137 (2008) 178-184
2. Bryson C.L., Ioannou G.N., Rulyak S.J., and Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension. Am. J. Epidemiol. 158 (2003) 1148-1153
3. Caro H.N., Sheikh N.A., Taverne J., Playfair J.H., and Rademacher T.W. Structural similarities among malaria toxins insulin second messengers, and bacterial endotoxin. Infect. Immun. 64 (1996) 3438-3441
4. Chaouat G. Current knowledge on natural killer cells, pregnancy and pre-eclampsia. Introduction. Reprod. Biomed. Online 16 (2008) 170-172
5. Deborde S., Schofield J.N., and Rademacher T.W. Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia. J. Reprod. Immunol. 59 (2003) 277-294
6. Dekker G., and Robillard P.Y. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J Reprod. Immunol. 76 (2007) 8-16
7. Elased K.M., Gumaa K.A., de Souza J.B., Playfair J.H., and Rademacher T.W. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols. Metabolism 53 (2004) 1048-1053
8. Elased K.M., Gumaa K.A., de Souza J.B., Rahmoune H., Playfair J.H., and Rademacher T.W. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs). Mol. Genet. Metab. 73 (2001) 248-258
9. Emery S.P., Levine R.J., Qian C., Ewell M.G., England L.J., Yu K.F., and Catalano P.M. Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension. BJOG 112 (2005) 1479-1485
10. Frick W., Bauer A., Bauer J., Wied S., and Muller G. Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action. Biochemistry 37 (1998) 13421-13436
11. Getahun D., Ananth C.V., Oyelese Y., Chavez M.R., Kirby R.S., and Smulian J.C. Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. Obstet. Gynecol. 110 (2007) 1319-1325
12. Gual P., Marchand-Brustel Y., and Tanti J.F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87 (2005) 99-109
13. Kennington A.S., Hill C.R., Craig J., Bogardus C., Raz I., Ortmeyer H.K., Hansen B.C., Romero G., and Larner J. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 323 (1990) 373-378
14. Kunjara S., Greenbaum A.L., Wang D.Y., Caro H.N., McLean P., Redman C.W., and Rademacher T.W. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol. Genet. Metab. 69 (2000) 144-158
15. Kunjara S., McLean P., Greenbaum A.L., and Rademacher T.W. Insight into the role of inositol phosphoglycans in insulin response and the regulation of glucose and lipid metabolism illustrated by the response of adipocytes from two strains of rats. Mol. Genet. Metab. 94 (2008) 263-266
16. Kunjara S., Wang D.Y., Greenbaum A.L., McLean P., Kurtz A., and Rademacher T.W. Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Mol. Genet. Metab. 68 (1999) 488-502
17. Kunjara S., Wang D.Y., McLean P., Greenbaum A.L., and Rademacher T.W. Inositol phosphoglycans and the regulation of the secretion of leptin: in vitro effects on leptin release from adipocytes and the relationship to obesity. Mol. Genet. Metab. 70 (2000) 61-68
18. Larner J. d-Chiro-inositol-its functional role in insulin action and its deficit in insulin resistance. Int. J. Exp. Diabetes Res. 3 (2002) 47-60
19. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., Schisterman E.F., Thadhani R., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., and Karumanchi S.A. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350 (2004) 672-683
20. Mackay A.P., Berg C.J., and Atrash H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 97 (2001) 533-538
21. Misek D.E., and Saltiel A.R. An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl phosphatidylinositol promotes protein dephosphorylation in rat epididymal adipocytes. Endocrinology 135 (1994) 1869-1876
22. Montoro M.N., Kjos S.L., Chandler M., Peters R.K., Xiang A.H., and Buchanan T.A. Insulin resistance and preeclampsia in gestational diabetes mellitus. Diabetes Care 28 (2005) 1995-2000
23. Ostlund I., Haglund B., and Hanson U. Gestational diabetes and preeclampsia. Eur. J Obstet. Gynecol. Reprod. Biol. 113 (2004) 12-16
24. Paine M.A., Scioscia M., Gumaa K.A., Rodeck C.H., and Rademacher T.W. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia. J. Reprod. Immunol. 69 (2006) 165-179
25. Rademacher T.W., Caro H., Kunjara S., Wang D.Y., Greenbaum A.L., and McLean P. Inositolphosphoglycan second messengers. Braz. J. Med. Biol. Res. 27 (1994) 327-341
26. Rademacher T.W., Gumaa K., and Scioscia M. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?. J. Reprod. Immunol. 76 (2007) 78-84
27. Redman C.W., and Sargent I.L. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 24 Suppl. A (2003) S21-S27
28. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
29. Robillard P.Y., Dekker G., Chaouat G., and Hulsey T.C. Etiology of preeclampsia: maternal vascular predisposition and couple disease-mutual exclusion or complementarity?. J. Reprod. Immunol. 76 (2007) 1-7
30. Robillard P.Y., and Hulsey T.C. Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet 347 (1996) 619
31. Saito S., and Sakai M. Th1/Th2 balance in preeclampsia. J. Reprod. Immunol. 59 (2003) 161-173
32. Scioscia M., Greco P., Selvaggi L.E., and Rademacher T.W. Is there a link between insulin resistance and inflammatory activation in preeclampsia?. Med. Hypoth. (2009)
33. Scioscia M., Gumaa K., Kunjara S., Paine M.A., Selvaggi L.E., Rodeck C.H., and Rademacher T.W. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J. Clin. Endocrinol. Metab. 91 (2006) 709-717
34. Scioscia, M., Gumaa, K., Selvaggi, L.E., Rodeck, C.H., Rademacher, T.W., in press. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. J. Perinat. Med.
35. Scioscia M., Gumaa K., Whitten M., Selvaggi L.E., Rodeck C.H., and Rademacher T.W. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies. J. Reprod. Immunol. 76 (2007) 85-90
36. Scioscia M., Kunjara S., Gumaa K., Gomez Galan A.M., McLean P., Rodeck C.H., and Rademacher T.W. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecol. Obstet. Invest. 64 (2007) 217-223
37. Scioscia M., Kunjara S., Gumaa K., McLean P., Rodeck C.H., and Rademacher T.W. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus. Diabet. Med. 24 (2007) 1300-1304
38. Scioscia M., Paine M.A., Gumaa K., Rodeck C.H., and Rademacher T.W. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension. J. Matern. Fetal Neonatal Med. 21 (2008) 581-585
39. Seely E.W., and Solomon C.G. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 88 (2003) 2393-2398
40. Shashkin P.N., Shashkina E.F., Fernqvist-Forbes E., Zhou Y.P., Grill V., and Katz A. Insulin mediators in man: effects of glucose ingestion and insulin resistance. Diabetologia 40 (1997) 557-563
41. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
42. Sowers J.R., Saleh A.A., and Sokol R.J. Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans. Am. J. Hypertens. 8 (1995) 1-4
43. Suzuki S., Kawasaki H., Satoh Y., Ohtomo M., Hirai M., Hirai A., Hirai S., Onoda M., Matsumoto M., and Hinokio Y. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care 17 (1994) 1465-1468
44. Varela-Nieto I., Leon Y., and Caro H.N. Cell signalling by inositol phosphoglycans from different species. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 115 (1996) 223-241
45. Vatten L.J., and Skjaerven R. Is pre-eclampsia more than one disease?. BJOG 111 (2004) 298-302
46. Virkamaki A., Ueki K., and Kahn C.R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103 (1999) 931-943
47. Williams P.J., Gumaa K., Scioscia M., Redman C.W., and Rademacher T.W. Inositol phosphoglycan P-type in preeclampsia: a novel marker?. Hypertension 49 (2007) 84-89
48. Xiong X., Demianczuk N.N., Saunders L.D., Wang F.L., and Fraser W.D. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am. J. Epidemiol. 155 (2002) 203-209